Quiver Bioscience vs Spark Therapeutics
Quiver Bioscience vs Spark Therapeutics, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Quiver Bioscience is on 36/100 and Spark Therapeutics on 58/100.
Where each one leads
Quiver Bioscience
Leads on none of the measures we hold for both companies.
Spark Therapeutics
- our overall score: 58/100 against 36/100
- domain rating: 80/100 against 36/100
At a glance
| Measure | Quiver Bioscience | Spark Therapeutics |
|---|---|---|
| What it is | Developing antisense oligonucleotide (ASO) therapies for rare genetic disorders. | A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases. |
| Category | Biotechnology, Pharmaceuticals, Rare Diseases, Genetics | Biotechnology, Gene Therapy, Healthcare, Pharmaceuticals |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Services |
| Founded | 2021 | 2013 |
| Headquarters | Cambridge, USA | Philadelphia, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Quiver Bioscience | Spark Therapeutics |
|---|---|---|
| Total funding | Not published | $82.8M |
| Latest round | Strategic Investment | Series B |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Quiver Bioscience | Spark Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 36/100 | 58/100 |
| Traction | Not published | 40/100 |
| Team | Not published | 90/100 |
| Search visibility | 13/100 | 13/100 |
| Quality | 58/100 | 65/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (36/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 36/100 | 80/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Quiver Bioscience | Spark Therapeutics |
|---|---|---|
| CDN | Cloudflare | Cloudflare |
| CMS | Webflow | Not detected |
| Frameworks | Not detected | Jquery |
| Analytics | Not detected | Google Tag Manager |
What users say
| Measure | Quiver Bioscience | Spark Therapeutics |
|---|---|---|
| Reddit sentimentThreads we track | Not published | 1 positive, 0 negative across 3 threads |
“The Daily Biotech Pulse: Pfizer Strikes $5.29B COVID Pill Supply Deal With US, Roche's Spark Therapeutics Reports Positive Gene Therapy Readout, EDAP Earnings.”r/conspiracy
Quiver Bioscience vs Spark Therapeutics: common questions
Which is better, Quiver Bioscience or Spark Therapeutics?
On our 0-100 score Spark Therapeutics rates higher (58/100 against 36/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.
How do Quiver Bioscience and Spark Therapeutics compare on the numbers?
Spark Therapeutics leads on our overall score (58/100 against 36/100), domain rating (80/100 against 36/100).
What do real users say about Quiver Bioscience and Spark Therapeutics?
Spark Therapeutics: 1 positive and 0 negative mentions across 3 Reddit threads we track, mostly in r/conspiracy.
Read the full Quiver Bioscience review and pricing or the Spark Therapeutics review and pricing. You can also browse other Quiver Bioscience alternatives we track.